Granite FO LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Granite FO LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$244K	Hold	1,550	–	–	0.13%	39
2026 Q2	$245K	Hold	1,550	–	–	0.13%	40
2026 Q1	$198K	Hold	1,550	–	–	0.12%	46
2025 Q4	$189K	Hold	1,550	–	–	0.1%	52
2025 Q3	$155K	Hold	1,550	–	–	0.08%	58
2025 Q2	$129K	Hold	1,550	–	–	0.07%	60
2025 Q1	$126K	Hold	1,550	–	–	0.07%	60
2024 Q4	$140K	Hold	1,550	–	–	0.08%	60
2024 Q3	$153K	Sell	1,550 -850	-35%	-$83.5K	0.09%	59
2024 Q2	$223K	Hold	2,400	–	–	0.14%	48
2024 Q1	$241K	Buy	2,400 +1,700	+243%	+$158K	0.14%	47
2023 Q4	$62.5K	Hold	700	–	–	0.04%	94
2023 Q3	$51.1K	Hold	700	–	–	0.04%	102
2023 Q2	$58.2K	Sell	700 -1,150	-62%	-$96.2K	0.04%	109
2023 Q1	$148K	Buy	+1,850	New	+$154K	0.09%	88

Other funds holding XBI

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return

Moss Adams Wealth Advisors Seattle, Washington $1.53B AUM 19.03% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Madrona Financial Services Everett, Washington $646M AUM 23.24% 1-Year Est. Return

Granite FO LLC's XBI Position: Q3 2026 in Review

Granite FO LLC held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 1,550 shares worth $244K. The position accounts for 0.13% of the portfolio, ranked #39.

Granite FO LLC first reported a position in XBI in Q1 2023 and has held it in 15 quarters since. The position peaked at $245K in Q2 2026. 382 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Granite FO LLC held 1,550 shares of State Street SPDR S&P Biotech ETF worth $244K as of Q3 2026.
Granite FO LLC left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
State Street SPDR S&P Biotech ETF made up 0.13% of Granite FO LLC's portfolio in Q3 2026, its #39 holding.
Granite FO LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 15 quarters since.
Granite FO LLC's State Street SPDR S&P Biotech ETF position peaked at $245K in Q2 2026.
382 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Granite FO LLC's 13F filing for Q3 2026, filed 14 Oct 2026.